405 related articles for article (PubMed ID: 17906634)
21. [Molecular mechanism and regulation of axon growth inhibition].
Yamashita T
Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
[TBL] [Abstract][Full Text] [Related]
22. Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.
Mi S; Pepinsky RB; Cadavid D
CNS Drugs; 2013 Jul; 27(7):493-503. PubMed ID: 23681979
[TBL] [Abstract][Full Text] [Related]
23. LINGO-1 shRNA Loaded by Pluronic F-127 Promotes Functional Recovery After Ventral Root Avulsion.
Ding L; Zhu Z; Wang Y; Zeng L; Wang T; Luo J; Zou TB; Li R; Sun X; Zhou G; Liu X; Wu HF
Tissue Eng Part A; 2019 Oct; 25(19-20):1381-1395. PubMed ID: 30794055
[TBL] [Abstract][Full Text] [Related]
24. Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury.
Ji B; Case LC; Liu K; Shao Z; Lee X; Yang Z; Wang J; Tian T; Shulga-Morskaya S; Scott M; He Z; Relton JK; Mi S
Mol Cell Neurosci; 2008 Oct; 39(2):258-67. PubMed ID: 18692574
[TBL] [Abstract][Full Text] [Related]
25. LINGO-1 Regulates Oligodendrocyte Differentiation through the Cytoplasmic Gelsolin Signaling Pathway.
Shao Z; Lee X; Huang G; Sheng G; Henderson CE; Louvard D; Sohn J; Pepinsky B; Mi S
J Neurosci; 2017 Mar; 37(12):3127-3137. PubMed ID: 28193690
[TBL] [Abstract][Full Text] [Related]
26. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.
Rudick RA; Mi S; Sandrock AW
Expert Opin Biol Ther; 2008 Oct; 8(10):1561-70. PubMed ID: 18774923
[TBL] [Abstract][Full Text] [Related]
27. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
28. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination.
Seifert T; Bauer J; Weissert R; Fazekas F; Storch MK
Acta Neuropathol; 2007 Feb; 113(2):195-203. PubMed ID: 17136549
[TBL] [Abstract][Full Text] [Related]
29. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
[TBL] [Abstract][Full Text] [Related]
30. LINGO-1 and its role in CNS repair.
Mi S; Sandrock A; Miller RH
Int J Biochem Cell Biol; 2008; 40(10):1971-8. PubMed ID: 18468478
[TBL] [Abstract][Full Text] [Related]
31. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation.
Pernet V; Joly S; Christ F; Dimou L; Schwab ME
J Neurosci; 2008 Jul; 28(29):7435-44. PubMed ID: 18632947
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional ultra-structures of myelin and the axons in the spinal cord: application of SEM with the osmium maceration method to the central nervous system in two mouse models.
Nomura T; Bando Y; Bochimoto H; Koga D; Watanabe T; Yoshida S
Neurosci Res; 2013 Mar; 75(3):190-7. PubMed ID: 23403366
[TBL] [Abstract][Full Text] [Related]
33. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
34. LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.
Jepson S; Vought B; Gross CH; Gan L; Austen D; Frantz JD; Zwahlen J; Lowe D; Markland W; Krauss R
J Biol Chem; 2012 Jun; 287(26):22184-95. PubMed ID: 22514275
[TBL] [Abstract][Full Text] [Related]
35. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
36. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
37. Myelin molecules limiting nervous system plasticity.
Schnaar RL
Prog Mol Subcell Biol; 2003; 32():125-42. PubMed ID: 12827974
[No Abstract] [Full Text] [Related]
38. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.
Bannerman PG; Hahn A; Ramirez S; Morley M; Bönnemann C; Yu S; Zhang GX; Rostami A; Pleasure D
Brain; 2005 Aug; 128(Pt 8):1877-86. PubMed ID: 15901645
[TBL] [Abstract][Full Text] [Related]
39. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats.
Tourbah A; Linnington C; Bachelin C; Avellana-Adalid V; Wekerle H; Baron-Van Evercooren A
J Neurosci Res; 1997 Dec; 50(5):853-61. PubMed ID: 9418972
[TBL] [Abstract][Full Text] [Related]
40. Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.
Kuhlmann T; Remington L; Cognet I; Bourbonniere L; Zehntner S; Guilhot F; Herman A; Guay-Giroux A; Antel JP; Owens T; Gauchat JF
Am J Pathol; 2006 Aug; 169(2):584-98. PubMed ID: 16877358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
